Increasing respiratory syncytial virus (RSV) vaccination among older adults could prevent up to 1600 deaths and 20,000 ...

RSV is the leading cause of infant hospitalization in the U.S.• Health officials urge vaccination for pregnant women, seniors ...

The adjusted pooled incidence of RSV among preschool children in primary care settings was 62.8 per 1,000 people in the ...

A wave of the highly contagious respiratory syncytial virus is beginning to wash over the United States, sending greater ...

The investigators used a test-negative case-control design to estimate the vaccine effectiveness (VE) of the RSVpreF (Abrysvo ...

RSV hospitalization rates in older adults reached 58.3 per 100,000 in winter 2023-24, nearly half the rate of influenza at 114.6 per 100,000. Mortality and clinical outcomes were comparable between ...

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study. The phase 3 randomized controlled trial ...

The shot's efficacy declined slightly compared with the levels of protection after one RSV season, but the new data suggests that the jab generally offers durable protection for adults ages 60 and ...

Respiratory syncytial virus prefusion F (RSVpreF) vaccine significantly reduced severe RSV-related lower respiratory tract disease (LRTD) requiring hospitalization or emergency department (ED) visits ...

Stephanie Mauro, now 76 years old, has had multiple sclerosis for more than 40 years. In 2020, when COVID-19 first appeared in the United States, her condition had worsened to the point where her pain ...

Among older adults in Spain, hospitalization rates from respiratory syncytial virus (RSV) infection increases progressively with age and is more likely among people with other health issues and who ...